Transport, enzymatic activity, and stability of mutant sulfamidase (SGSH) identified in patients with mucopolysaccharidosis type III A
- 22 April 2004
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 23 (6) , 559-566
Abstract
Mucopolysaccharidosis type IIIA (MPSIIIA) is an autosomal recessive lysosomal storage disease caused by mutations in the N‐sulfoglucosamine sulfohydrolase gene (SGSH; encoding sulfamidase, also sulphamidase) leading to the lysosomal accumulation and urinary excretion of heparan sulfate. Considerable variation in the onset and severity of the clinical phenotype is observed. We report here on expression studies of four novel mutations: c.318C>A (p.Ser106Arg), c.488T>C (p.Leu163Pro), c.571G>A (p.Gly191Arg), and c.1207_1209delTAC (p.Tyr403del), and five previously known mutations: c.220C>T (p.Arg74Cys), c.697C>T (p.Arg233X), c.1297C>T (p.Arg433Trp), c.1026dupC (p.Leu343fsX158), and c.1135delG (p.Val379fsX33) identified in MPSIIIA patients. Transient expression of mutant sulfamidases in BHK or CHO cells revealed that all the mutants were enzymatically inactive with the exception of c.318C>A (p.Ser106Arg), which showed 3.3% activity of the expressed wild‐type enzyme. Western blot analysis demonstrated that the amounts of expressed mutant sulfamidases were significantly reduced compared with cells expressing wild type. No polypeptides were immunodetectable in extracts of cells transfected with the cDNA carrying the c.697C>T (p.Arg233X) nonsense mutation. In vitro translation and pulse‐chase experiments showed that rapid degradation rather than a decrease in synthesis is responsible for the low, steady‐state level of the mutant proteins in cells. The amounts of secreted mutant precursor forms, the cellular stability, the proteolytic processing, and data from double‐label immunofluorescence microscopy suggest that the degradation of the majority of newly synthesized c.220C>T (p.Arg74Cys), c.571G>A (p.Gly191Arg), c.1297C>T (p.Arg433Trp), c.1026dupC (p.Leu343fsX158), and c.1135delG (p.Val379fsX33) mutant proteins probably occurs in the ER, whereas c.488T>C (p.Leu163Pro) mutant protein showed instability in the lysosomes. Hum Mutat 23:559–566, 2004.Keywords
This publication has 16 references indexed in Scilit:
- Secretion of phosphomannosyl-deficient arylsulphatase A and cathepsin D from isolated human macrophagesBiochemical Journal, 2002
- Heparan N-sulfatase gene: two novel mutations and transient expression of 15 defectsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutationsHuman Mutation, 1998
- Mutation 1091delC is highly prevalent in Spanish Sanfilippo syndrome type A patientsHuman Mutation, 1998
- Recombinant human sulphamidase: expression, amplification, purification and characterizationBiochemical Journal, 1998
- The sulfatase gene familyCurrent Opinion in Genetics & Development, 1997
- Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A)Human Mutation, 1997
- A fluorimetric enzyme assay for the diagnosis of sanfilippo disease type A (MPS IIIA)Journal of Inherited Metabolic Disease, 1995
- Management of mucopolysaccharidosis type III.Archives of Disease in Childhood, 1993
- Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic propertiesBiochemical Journal, 1986